GEN Exclusives

More »

GEN News Highlights

More »
Mar 24, 2009

Two U.K. Institutes Join GeneGo’s MetaMiner CNS Partnership Program

  • The NIHR Biomedical Research Centre for Mental Health and King's College London (BRC-MH) have joined GeneGo’s MetaMiner CNS Partnership Program. The goal is to develop a central nervous system (CNS) pathway-analysis platform, which includes developing a series of disease pathway maps for schizophrenia, Alzheimer’s disease, and Huntington's disease. The program will also leverage experimental data from the public domain and make it available for analysis.


Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »